Related Experiment Video
Updated: Jan 26, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Incidence and survival of peritoneal malignant mesothelioma between 1989 and 2015: A population-based study
N Le Stang1, V Bouvier2, O Glehen3
1Multicenter National Mesothelioma Registry (MESONAT), Léon Bérard Cancer Center, Lyon, F-69008, France; FRANCIM Network, Toulouse, F-31000, France.
Background:
Peritoneal malignant mesothelioma is a rare disease for which few population-based studies are available. The aim of this study was to describe the evolution of the incidence and survival of peritoneal malignant mesothelioma in France between 1989 and 2015, using data derived from the French network of cancer registries.
Methods:
Age world-standardized incidence rates and overall survival were calculated using data from 16 French cancer registries. Log-linear Poisson regression analysis was used to estimate the average annual percentage change in incidence rates. Overall survival was performed using age-adjusted Cox proportional hazards model.
Results:
In French men, the incidence has increased quietly over the reporting period from 0.07 to 0.10 with a maximum of 0.16 per 100,000 persons-years in 2001-2003. For women, the increase in incidence has been lower than for men over the period 1989-2015, ranging from 0.04 to 0.11. A better prognosis was associated with a diagnosis made after 2000 (HR = 1.76; p = 0.013), the epithelioid histological type (p = 0.003), and the fact of being a woman, which has a 5-year risk of death half that of men (HR = 0.55; p = 0.001), regardless of age, diagnosis period or histology.
Conclusion:
Our results are similar to those currently available for other countries. In France, peritoneal mesothelioma remains a rare and fatal cancer with a small increase in the incidence rate since 1989 and a median survival of 1 year; it seemed to develop equally in women and men over this period of time.
Insights
Peritoneal malignant mesothelioma incidence slightly increased in France from 1989-2015. Survival improved for diagnoses after 2000, epithelioid type, and women, who have a better prognosis.
Area of Science:
- Oncology
- Epidemiology
- Public Health
Background:
- Examines the incidence and survival trends of peritoneal malignant mesothelioma in France.
- Utilizes data from the French network of cancer registries spanning 1989-2015.
- Addresses the rarity of population-based studies for this disease.
Observation:
- Incidence in men rose from 0.07 to 0.10 per 100,000 person-years.
- Incidence in women showed a lower increase, ranging from 0.04 to 0.11.
- Median survival remains approximately 1 year.
Findings:
- A diagnosis after 2000 significantly improved prognosis (HR=1.76, p=0.013).
- Epithelioid histological type was associated with better survival (p=0.003).
- Women had a 5-year mortality risk half that of men (HR=0.55, p=0.001).
Implications:
- Highlights improved survival factors for peritoneal mesothelioma.
- Suggests potential for targeted interventions based on histology and sex.
- Underscores the need for continued surveillance of this rare cancer.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Conservation of Small Populations
What is Population Genetics?
Survival Tree
Building a Survival Tree
Constructing a...
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...

